Authors
Ramage, JKValle, Juan W
Dijkum, EJMN
Sundin, A
Pascher, A
Couvelard, A
Kloeppel, G
The ENETS 2016 Munich Advisory Board Participants
Affiliation
Department Gastroenterology, Hampshire Hospitals NHS Trust, Kings College Hospital ENETS centre of Excellence, BasingstokeIssue Date
2019
Metadata
Show full item recordAbstract
The subject of colorectal neuroendocrine neoplasms (NENs), subdivided into well-differentiated NENs, termed neuroendocrine tumours (NETs; grade (G) 1 and 2), and poorly differentiated NENs, termed neuroendocrine carcinomas (NECs; G3) according to the 2010 World Health Organisation (WHO) classification, has arguably not had as much attention or study as NENs occurring in other sites. Colorectal NETs and NECs are however easier to study than many others since they are usually not difficult to remove and are increasingly detected because of intensified colorectal cancer screening and surveillance programmes. Colorectal NETs and NECs show site-specific heterogeneity with variable behaviour and different therapeutic options; these various aspects provide unique challenges. Because of bowel cancer screening programmes, colorectal NENs, like conventional adenocarcinomas, may be diagnosed at a stage that is associated with improved survival. In this article we intend to describe and define areas of unmet needs relating to the epidemiology, classification, pathology, diagnosis and therapy of colorectal NETs (including NETs G3), colorectal NECs, and finally, mixed adeno-neuroendocrine carcinomas (MANECs) by reviewing and discussing the relevant literature.Citation
Ramage JK, Valle JW, Nieveen van Dijkum EJM, Sundin A, Pascher A, Couvelard A, et al. Colorectal neuroendocrine neoplasms: areas of unmet need. Neuroendocrinology. 2019;108(1):45-53.Journal
NeuroendocrinologyDOI
10.1159/000493767PubMed ID
30219817Additional Links
https://dx.doi.org/ 10.1159/000493767Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1159/000493767
Scopus Count
Collections
Related articles
- Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE).
- Authors: Nuñez-Valdovinos B, Carmona-Bayonas A, Jimenez-Fonseca P, Capdevila J, Castaño-Pascual Á, Benavent M, Pi Barrio JJ, Teule A, Alonso V, Custodio A, Marazuela M, Segura Á, Beguiristain A, Llanos M, Martinez Del Prado MP, Diaz-Perez JA, Castellano D, Sevilla I, Lopez C, Alonso T, Garcia-Carbonero R
- Issue date: 2018 Apr
- World Health Organization grading classification for pancreatic neuroendocrine neoplasms: a comprehensive analysis from a large Chinese institution.
- Authors: Yang M, Zeng L, Ke NW, Tan CL, Tian BL, Liu XB, Xiang B, Zhang Y
- Issue date: 2020 Sep 22
- Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms.
- Authors: Klöppel G
- Issue date: 2011 Oct
- Gastroenteropancreatic neuroendocrine neoplasms G3: Novel insights and unmet needs.
- Authors: Shi M, Fan Z, Xu J, Yang J, Li Y, Gao C, Su P, Wang X, Zhan H
- Issue date: 2021 Dec
- Neuroendocrine Neoplasms: Dichotomy, Origin and Classifications.
- Authors: Klöppel G
- Issue date: 2017 Oct